Tue, 30 Oct 2018 19:53:04 GMT
Allergan disappointed with buyer interest in its business units
On Tuesday, Allergan's CEO Brent Saunders stated that the early offers proposed by possible buyers for its business units, which had been put up for a sale, undervalued the firms, sending the company's shares down over 6%.